Stay informed on the latest Truth Social posts from Donald Trump (@realDonaldTrump) without the doomscrolling. Consider it a public service for your mental health. (Why?)
Filtering by entity: American Taxpayers | Clear Filter
Summary:Donald Trump announces the Trump Gold Card, priced at $1 million for individuals and $2 million for corporations, as a solution to generate over $100 billion quickly. The funds will be allocated to reducing taxes, supporting pro-growth projects, and paying down national debt, addressing concerns about illegal immigration and a broken immigration system.
Sentiment:Campaigning
Key Claims:
- The Trump Gold Card is available for $1 million for individuals and $2 million for corporations.
- The card is anticipated to generate over $100 billion quickly.
- Generated funds will be used for reducing taxes, pro-growth projects, and paying down national debt.
- The country has millions of illegal aliens pouring in, and the immigration system is broken.
- The American people and taxpayers should benefit from the legal immigration system.
Potential Market Impact (S&P 500):4/10
Potential Geopolitical Risk:0/10
Potential Global Cross-Asset Impact:5/10
Summary:A letter from the White House dated July 31, 2025, sent to Amgen, demands that drug manufacturers implement actions within 60 days, by September 29, 2025, to lower prescription drug prices for American patients to Most-Favored-Nation rates. The letter asserts that the US currently pays significantly more for brand name drugs than other developed nations due to 'global freeloading' and highlights an Executive Order signed on May 12, 2025, aimed at addressing this disparity.
Sentiment:Directive
Key Claims:
- An Executive Order titled 'Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients' was signed on May 12, 2025.
- Brand name drug prices in the United States are up to three times higher than elsewhere, attributed to 'global freeloading' and an 'unacceptable burden' on American families.
- Amgen and all manufacturers are called upon to implement specific actions within 60 days to address inflated drug prices.
- Required actions include extending Most-Favored-Nation (MFN) pricing to Medicaid, guaranteeing MFN pricing for newly-launched drugs, returning increased revenues from abroad to American patients and taxpayers, and providing for direct purchasing at MFN pricing.
- The administration is prepared to deploy 'every tool in our arsenal' to protect American families from 'abusive drug pricing practices' if manufacturers do not comply.
- The deadline for achieving these goals is September 29, 2025.
Potential Market Impact (S&P 500):8/10
Potential Geopolitical Risk:2/10
Potential Global Cross-Asset Impact:7/10
« Previous
Page 1 of 1
Next »